explore -WSS

explore

author：focus 2025-09-06 04:17:30 - browse：9864

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

WSS

Steward Health Care has deal to sell doctor network to UnitedHealth

Abortion pill Supreme Court ruling could impact entire drug industry

Patient advocates debate FDA's accelerated approval process

Elizabeth Warren probes abortion access

New rules on organ donation and transplantation 'will bring chaos'

Why the world’s most expensive drug might be worth the price

hotspot

explore

entertainment

How to save PrEP access — and even expand it

Supreme Court mifepristone arguments center on docs' right to sue

George Santos makes 1st court appearance after pleading not guilty to 13 counts

In new study, freeze

Apple is now the first public company to be valued at $3 trillion

Russian special forces kill a gunman who broke into a private house near Moscow

Activists slam private health insurers over coverage restrictions

What to know about Saharan dust affecting the US and how it can affect health

23andMe had bad news about my health. I wish a person had delivered it

Review: 'Barbie' will hit you like a shot in the heart

knowledge

Elizabeth Warren probes abortion access

Readout LOUD podcast: mifepristone case, GLP

Our daughter's deadly disease: trisomy 18. We wanted to protect her

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

Patient advocates debate FDA's accelerated approval process

Organ transplantation is at a crossroads. Major reform is needed

leisure time

entertainment

leisure time

entertainment